Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profiles
Open accessThe DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
HIV-1 infection is a manageable chronic condition, with non-nucleoside HIV-1 reverse transcriptase inhibitors (NNRTIs) remaining a cornerstone of antiretroviral therapy. Nevertheless, drug resistance to existing therapeutics is a serious and immediate concern. Using structure-based and scaffold-hopping approaches, we designed evolved diarylpyrimidine analogs targeting reverse transcriptase (RT), exploiting chemical space surrounding the NNRTI-binding pocket. We identified compounds 5i3 and 5e2 , with robust antiviral efficacy against wild-type HIV-1 and rilpivirine-resistant strains. Encouragingly, in vitro selection of mutant strains with 5i3 took 39 passages to select resistance, with no phenotypic cross-resistance observed with known RT drugs. Co-crystal structures of wild-type and mutant RT with 5i3 and 5e2 revealed their resilience toward resistance mutations due to enhanced conformational flexibility and positional adaptability. 5i3 exhibited good pharmacokinetic properties and favorable safety profiles, without substantial cytochrome P450 inhibition, and excellent oral bioavailability. These derivatives represent a promising scaffold for the development of anti-HIV drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NNRTIs inhibit HIV-1 reverse transcriptase (RT) by binding to a specific, non-catalytic hydrophobic pocket known as the non-nucleoside inhibitor binding pocket (NNIBP). This binding site is located approximately 10 Å from the polymerase active site. The interaction induces conformational changes in RT that disrupt its enzymatic function, thereby inhibiting viral DNA synthesis (40, 45).”
From Research progress on HIV-1 structural proteins and antiviral therapies (2026) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 2×
“Manual superposition and evaluation of WT and resistant mutant RT structures with NNRTIs were performed with Coot ( 71 ).”
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
(2007) · PubMed · Cited by 953
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
Polder maps: improving OMIT maps by excluding bulk solvent
Liebschner, D., Afonine, P. V., Moriarty, N. W., Poon, B. K., Sobolev, O. V., Terwilliger, T. C., & Adams, P. D. (2017) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316018210 · Cited by 657
Cited by
Research progress on HIV-1 structural proteins and antiviral therapies
Wang, H., Yuan, J., & Wang, H. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1805597 · Cited by 2
Quinoline derivatives as potential anti-cancer agents and their SARs elucidation
Wan, Y., Xiao, C., Jiayi, 张. Z., Wang, J., 周乐, Li, D., & Tang, Z. (2026) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2026.146318 · Cited by 3
Zhang, Y.-X., Pannecouque, C. C., Clercq, E. D., Tramontano, E., Corona, A., Dettori, L., Tran, P., Li, X.-D., Su, S., Wang, S., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02556 · Cited by 1
Self-citationRecent Developments in HIV Antivirals: The Prospect of Prophylactic Drugs to Change the Pandemic
Brüssow, H. (2026) · Microbial Biotechnology · doi:10.1111/1751-7915.70317 · Cited by 1
Light-independent antimicrobial and acaricidal Ag/TiO₂ exhibited reduced allergenicity
Liu, X., Sun, J., Galluzzi, M., Zhong, H., Zhou, Z., & Chen, S. (2026) · Advanced Composites and Hybrid Materials · doi:10.1007/s42114-026-01793-9 · Cited by 1
Self-citation
Metadata
- Authors
- Wang, Z., Rumrill, S., Kang, D., Guma, S. D., Feng, D., De Clercq, E., Pannecouque, C., Chen, C. H., Arnold, E., Ruiz, F. X., Liu, X., & Zhan, P.
- Affiliations
- Shandong University (CN)
- Rutgers, The State University of New Jersey (US)
- Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, K.U. Leuven, Herestraat 49 Postbus 1043 (09.A097), B-3000 Leuven, Belgium.
- Rega Institute for Medical Research (BE)
- Duke Medical Center (US)
- Corresponding author
- Wang, Zhao
- Rumrill, Shawn
- Kang, Dongwei
- Guma, Samuel Desta
- Chen, Chin Ho
- Arnold, Eddy
- Ruiz, Francesc Xavier
- Liu, Xinyong
- Zhan, Peng
- ORCID
- Venue
- Science Advances
- Published
- 2025-05-30
- Volume
- 11
- Issue
- 22
- Pages
- eadt8916-eadt8916
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC12124364
- OpenAlex
- W4410886466
- Cited by
- 7
- References
- 74
- Citations by year
- 2026: 6 · 2025: 1
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lirias (submittedVersion, cc-by-nc)
- Funders
- Shandong University (SYS202205)
- Ministry of Science and Technology of the People's Republic of China (2019ZX09301-126)
- Natural Science Foundation of Shandong Province (ZR2020JQ31, ZR2020YQ61)
- National Institutes of Health
- National Institute of General Medical Sciences (GM135141, GM008339, T32GM008339)
- National Institute of Allergy and Infectious Diseases (R01AI027690)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1, non-nucleoside reverse transcriptase inhibitors, drug resistance, reverse transcriptase, structure-based drug design, scaffold hopping, antiviral efficacy, pharmacokinetics, oral bioavailability, cytochrome P450 inhibition, co-crystal structure, conformational flexibility
- MeSH terms
- Rilpivirine, Animals, Humans, Microbial Sensitivity Tests, Mutation, Structure-Activity Relationship, HIV-1, HIV Infections, Reverse Transcriptase Inhibitors, Anti-HIV Agents, Drug Resistance, Viral, HIV Reverse Transcriptase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.